BMY FY 2017 Earnings — Bristol-Myers Squibb Company Revenue & Financial Results | Market Cap Arena

BMYBristol-Myers Squibb Company

$121B

FY 2017 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$20.8B+6.9% YoY

Gross Profit

$15.0B72.0% margin

Operating Income

$5.2B25.2% margin

Net Income

$1.0B4.8% margin

EPS (Diluted)

$0.61

Cash Flow

Operating Cash Flow

$5.3B

Free Cash Flow

$4.2B

Stock-Based Comp.

$199M

Balance Sheet

Total Assets

$33.6B

Total Liabilities

$21.7B

Stockholders' Equity

$11.7B

Cash & Equivalents

$5.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20.8B	$19.4B	+6.9%
Gross Profit	$15.0B	$14.5B	+3.2%
Operating Income	$5.2B	$5.2B	+1.2%
Net Income	$1.0B	$4.5B	-77.4%